Solid Biosciences Inc.
SLDB | NASDAQ
$8.54
-$0.37 (-4.15%)
At close: Sep 21, 2026, 4:00 PM ET
$9.10
+$0.56 (+6.56%)
Pre-market:
Sep 22, 2026, 8:37 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 8.09M | 13.62M | n/a |
Cost of Revenue | 1.64M | 2.46M | 2.58M | n/a | n/a | 3.92M |
Gross Profit | -1.64M | -2.46M | -2.58M | 8.09M | 13.62M | -3.92M |
Operating Income | -179.21M | -129.73M | -104.32M | -106.45M | -72.25M | -86.46M |
Interest Income | 9.9M | 9.47M | 7.14M | 2.62M | 64K | 115K |
Pretax Income | -174.33M | -124.7M | -96.02M | -85.98M | -72.19M | -88.29M |
Net Income | -174.33M | -124.7M | -96.02M | -85.98M | -72.19M | -88.29M |
Selling & General & Admin | 38.88M | 33.3M | 27.75M | 28.95M | 27.14M | 21.58M |
Research & Development | 140.33M | 96.43M | 76.56M | 78.42M | 58.74M | 64.88M |
Other Expenses | -1.64M | -2.46M | -2.58M | 7.18M | n/a | -3.92M |
Operating Expenses | 177.57M | 127.27M | 101.73M | 114.55M | 85.87M | 82.54M |
Interest Expense | n/a | 340K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 179.21M | 129.73M | 104.32M | 114.55M | 85.87M | 86.46M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 87.5M | 40.82M | 19.88M | 8.51M | 7.12M | 3.46M |
Shares Outstanding (Diluted) | 87.5M | 40.82M | 19.88M | 8.51M | 7.12M | 3.46M |
EPS (Basic) | -1.99 | -3.06 | -4.83 | -10.10 | -10.14 | -25.50 |
EPS (Diluted) | -1.99 | -3.06 | -4.83 | -10.10 | -10.14 | -25.50 |
EBITDA | -172.69M | -121.9M | -93.43M | -96.87M | -69.22M | -84.37M |
EBIT | -174.33M | -124.36M | -96.02M | -99.27M | -72.19M | -88.29M |
Depreciation & Amortization | 1.64M | 2.46M | 2.58M | 2.41M | 2.96M | 3.92M |
Add to Watchlist
Select watchlists to add or remove SLDB